Union Korea Pharm Co., Ltd. (KOSDAQ: 080720)

Union Korea Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,832	6,579	6,012	20,659	1,558	5,194
Short-Term Investments	1,494	602.13	1,513	461.34	1,576	1,305
Cash & Short-Term Investments	4,326	7,181	7,524	21,120	3,134	6,498
Cash Growth	-24.74%	-4.57%	-64.37%	573.85%	-51.77%	-53.57%
Accounts Receivable	25,068	33,520	33,092	26,147	25,245	32,827
Other Receivables	334.84	748.69	631.13	644.7	1,129	1,856
Receivables	25,403	34,269	33,723	26,792	26,374	34,683
Inventory	13,260	7,910	12,731	10,747	13,647	11,000
Prepaid Expenses	71.95	91.99	76.39	69.3	62.05	59
Other Current Assets	1,280	230.35	515.5	53.99	827.27	98.48
Total Current Assets	44,341	49,683	54,570	58,782	44,045	52,340
Property, Plant & Equipment	34,175	34,596	44,613	43,787	39,996	33,414
Long-Term Investments	2,411	2,617	2,450	2,454	2,147	2,386
Other Intangible Assets	827.31	1,081	1,539	1,751	2,012	1,179
Long-Term Deferred Tax Assets	4,973	4,973	8,710	10,564	7,104	4,286
Other Long-Term Assets	923.43	1,266	399.86	1,436	1,578	2,434
Total Assets	87,860	94,425	112,523	119,044	97,183	96,428
Accounts Payable	3,025	2,884	3,080	2,697	2,648	3,253
Accrued Expenses	1,432	1,574	1,013	950.45	835.6	981.73
Short-Term Debt	21,954	34,902	33,966	10,500	9,800	17,250
Current Portion of Long-Term Debt	-	1,200	-	4,000	-	824.88
Current Portion of Leases	322.84	167.26	127.24	280	478.58	349.59
Current Income Taxes Payable	-	-	-	-	-	589.35
Other Current Liabilities	33,200	18,282	20,806	24,793	9,264	5,095
Total Current Liabilities	59,935	59,009	58,992	43,220	23,026	28,343
Long-Term Debt	3,000	3,000	3,000	21,026	4,871	8,961
Long-Term Leases	274.56	80.13	31.79	61.48	140.49	141.4
Other Long-Term Liabilities	599.97	486.02	608.58	522.72	302.73	224.06
Total Liabilities	65,667	64,101	63,910	65,445	28,814	38,379
Common Stock	3,956	3,955	3,952	3,952	3,952	2,952
Additional Paid-In Capital	47,339	47,324	47,299	47,299	47,299	28,459
Retained Earnings	-21,864	-13,717	4,654	5,663	16,561	26,022
Treasury Stock	-7,309	-7,309	-7,309	-4,592	-	-
Comprehensive Income & Other	70.89	70.88	16.38	18.9	557.53	615.49
Total Common Equity	22,193	30,324	48,612	52,341	68,369	58,048
Shareholders' Equity	22,193	30,324	48,612	53,599	68,369	58,048
Total Liabilities & Equity	87,860	94,425	112,523	119,044	97,183	96,428
Total Debt	25,552	39,349	37,125	35,867	15,290	27,526
Net Cash (Debt)	-21,226	-32,169	-29,601	-14,747	-12,155	-21,028
Net Cash Per Share	-3024.01	-4455.02	-4011.66	-1897.72	-1829.35	-3561.81
Filing Date Shares Outstanding	5.66	7.23	7.22	7.56	7.9	5.9
Total Common Shares Outstanding	5.66	7.23	7.22	7.56	7.9	5.9
Working Capital	-15,594	-9,327	-4,422	15,562	21,019	23,996
Book Value Per Share	3924.34	4196.34	6732.64	6925.43	8650.23	9832.50
Tangible Book Value	21,366	29,243	47,073	50,590	66,357	56,869
Tangible Book Value Per Share	3778.05	4046.81	6519.47	6693.77	8395.61	9632.75
Land	6,905	6,905	6,681	6,656	6,449	6,449
Buildings	19,282	19,817	24,223	25,073	21,732	19,933
Machinery	1,290	1,885	3,450	4,732	5,233	3,766
Construction In Progress	6,026	5,382	9,172	5,512	3,786	329

Source: S&P Capital IQ. Standard template. Financial Sources.